Summarized by Masters of Longevity from Longevity Technology.
A US patent was granted for a new buntanetap crystal form as Phase 3 nears.

Key Takeaways
- Annovis was granted a buntanetap patent through 2044.
- The patent was for the crystal form used in Phase 3.
- Different crystal forms are treated as legally distinct drugs.



